The global acute coronary syndrome market is anticipated to witness lucrative growth over the forecast period owing to increasing incidences of life style associated disorders such as of diabetes, rising level of hypertension and obesity. Acute Coronary Syndrome (ACS) may result in chest pain, vomiting or sweating and might reduce blood flow to the heart, which may lead to stroke or heart attack. Factors such as rising consumption of alcohol, cigarette and drugs are the vital drivers for this market over the forecast period. Rapid changing lifestyle coupled with change in food habits are boosting the growth of ACS market in coming seven years. Favorable government policies for early stage disease diagnosis coupled with increasing healthcare reimbursement policies are anticipated to drive the global ACS market.
Access This Full Report on Acute Coronary Syndrome Market with TOC:
Antihypertensive drug is anticipated to witness significant growth over the forecast period owing to increasing incidences for stroke, high blood pressure and myocardial infarction. Due to highly efficient treatment line for blood clots, antithrombotic market is expected to show lucrative growth during the forecast period. Other drugs such as antihypertensive and statin drugs are also expected to witness lucrative growth due to increasing incidences of lifestyle associated conditions. On the basis of types, the UA (Unstable Angina) segment is likely to witness the fastest growth rate over the forecast period. NSTEMI (non-ST-elevation myocardial infarction) segment is also expected to show high growth in coming seven years due to growing number of partial heart block by blood clot.
Regionally, the global ACS market was dominated by North America, in 2014. Due to huge investment in research and development coupled with rapid introduction of new drugs into the market, this region is anticipated to maintain its dominance over the forecast period. Asia Pacific region is expected to show the fastest growth in coming seven years owing to increasing healthcare expenditure, growing medical tourism and rising outsourcing activities.
See More Reports of This Category by Grand View Research at:
The global acute coronary syndrome market is highly competitive and consolidated in nature due to the presence of large number of market players. Few of them are Portal Pharmaceuticals, Dr. Reddy’s Laboratories, Sankyo, Teva Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Regeneron, AbbVie, Johnson & Johnson, GlaxoSmithKline, and Eli Lilly.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
For More Information, Visit: http://www.grandviewresearch.com/
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States